Enoxaparin Sodium Injection
Product Images NDC 0955-1010

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 0955-1010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enoxaparin Winthrop 01

An instructional illustration showing two gloved hands handling a syringe with a cap. One hand is removing or attaching the syringe cap, as indicated by a double-headed blue arrow pointing left and right between the hands.*

FDA Label Image

Enoxaparin Winthrop 02

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the skin of an arm. The image emphasizes the injection technique for a subcutaneous route, consistent with injection instructions for enoxaparin sodium.*

FDA Label Image

Enoxaparin Winthrop 03

An instructional illustration showing a hand administering an Enoxaparin sodium injection subcutaneously. The image depicts the syringe angled toward the skin with an arrow indicating the injection direction.*

FDA Label Image

Enoxaparin Winthrop 04

An instructional illustration showing a hand holding an Enoxaparin sodium injection prefilled syringe, with a blue arrow indicating the direction to press the plunger for injection. The syringe is shown with a visible drug chamber and needle cap, demonstrating proper injection technique for subcutaneous administration.*

FDA Label Image

Enoxaparin Winthrop 05

An instructional illustration showing a gloved hand disposing of a syringe into a container labeled with a red biohazard symbol. The image emphasizes safe disposal of used injection equipment in a biohazard sharps container.*

FDA Label Image

Enoxaparin Winthrop 06

Chemical structure diagram depicting the molecular structure of enoxaparin sodium. The image shows repeating sugar units with various substituents, including sodium carboxylate groups, hydroxyl groups, and amino groups. Structural details clarify that R1 can be hydrogen or SO3Na and R2 can be SO3Na or COCH3.*

FDA Label Image

Enoxaparin Winthrop 07

Chemical structure diagram of enoxaparin sodium, showing its key molecular components including sodium carboxylate, hydroxyl groups, and sulfate groups, as part of its complex polysaccharide structure.*

FDA Label Image

Enoxaparin Winthrop 08

A forest plot chart illustrating the relative risk comparison between UFH (unfractionated heparin) and Enoxaparin sodium across various patient subgroups. The chart includes data points with confidence intervals and tabulated percentage values for UFH, Enoxaparin, and calculated risk reduction. Subgroups include sex, age, infarct location, diabetes status, prior MI, fibrinolytic agent type, time to treatment, and PCI within 30 days, with an overall summary at the bottom. The x-axis scales from 0.50 to 1.50 indicating relative risk favoring Enoxaparin on the left and UFH on the right.*

FDA Label Image

Enoxaparin Winthrop 09

A Kaplan-Meier curve chart comparing the hazard distribution function for time to death or myocardial re-infarction (days) between Enoxaparin sodium (Enox) and unfractionated heparin (UFH). The chart includes data points over 30 days and an inset graph showing one-year data. The number of patients at risk is listed for both treatments at various time points. Significant differences between groups are indicated by log-rank test p-values.*

FDA Label Image

Enoxaparin Winthrop 10

An instructional illustration showing an Enoxaparin sodium injection syringe before and after use. The 'Before Use' side labels the needle cap, needle, and plunger rod. The 'After Use' side shows the needle covered by a protective sleeve with the plunger rod extended.*

FDA Label Image

Enoxaparin Winthrop 11

An instructional illustration showing components for subcutaneous injection of Enoxaparin Sodium. It includes a prefilled syringe labeled Enoxaparin Sodium, a cotton ball or gauze, a sharps disposal container, an alcohol wipe, and a small adhesive bandage, demonstrating the items needed for safe injection and disposal.*

FDA Label Image

Enoxaparin Winthrop 12

An instructional illustration showing hands removing a protective backing from a prefilled injection syringe, likely for Enoxaparin sodium subcutaneous injection. The image demonstrates preparation steps before administration.*

FDA Label Image

Enoxaparin Winthrop 13

Illustration showing a detailed drawing of a syringe prefilled with enoxaparin sodium injection. The image includes a label area indicating the expiration date location on the syringe barrel.*

FDA Label Image

Enoxaparin Winthrop 14

An instructional diagram showing a syringe labeled as containing a clear liquid. The illustration highlights the clarity of the liquid inside the syringe barrel and includes the syringe plunger and needle cap, representing a subcutaneous injection device.*

FDA Label Image

Enoxaparin Winthrop 15

An instructional illustration showing the front torso area with two gray rectangles on the left and right sides, likely indicating recommended subcutaneous injection sites for Enoxaparin sodium injection. The image is simple and schematic with a central marking between the two shaded injection areas.*

FDA Label Image

Enoxaparin Winthrop 16

An instructional illustration showing a hand applying or pressing a small adhesive patch or injection site on the lower abdomen of a person. The drawing likely demonstrates the proper placement or administration area for a subcutaneous injection.*

FDA Label Image

Enoxaparin Winthrop 17

An instructional illustration showing two hands removing the cap from a syringe, indicated by bidirectional arrows pointing left and right, demonstrating how to access the needle of an injection syringe for subcutaneous administration.*

FDA Label Image

Enoxaparin Winthrop 18

Instructional illustration showing a hand holding a syringe with an instruction to set the dose by pulling the plunger. The image demonstrates the step of adjusting the dose before injection, relevant for an enoxaparin sodium subcutaneous injection syringe.*

FDA Label Image

Enoxaparin Winthrop 19

An instructional illustration showing a hand gripping the waistband of pants or underwear near the lower abdomen, likely demonstrating the correct site for subcutaneous injection administration.*

FDA Label Image

Enoxaparin Winthrop 20

Instructional diagram showing the proper technique for subcutaneous injection into the abdomen. It depicts a hand holding a syringe at a 90-degree angle to the skin, with another hand pinching the skin to prepare for injection.*

FDA Label Image

Enoxaparin Winthrop 21

An instructional diagram showing a person preparing to administer a subcutaneous injection in the abdominal area. The image depicts one hand pinching the skin while the other hand inserts a syringe at an angle into the skin fold. An arrow indicates the direction of the injection.*

FDA Label Image

Enoxaparin Winthrop 22

An instructional illustration showing the technique for subcutaneous injection, depicting a hand pinching skin on the abdomen and the other hand holding a syringe with the needle poised for injection at a right angle to the skin.*

FDA Label Image

Enoxaparin Winthrop 23

Illustration showing a hand holding an injection syringe with a protective sleeve, demonstrating the step to click and remove the sleeve, likely part of instructions for preparing an enoxaparin sodium injection for subcutaneous use.*

FDA Label Image

Enoxaparin Winthrop 24

An instructional illustration showing a hand placing a syringe with a needle cap into a labeled sharps disposal container. The syringe and needle cap are clearly labeled, emphasizing safe disposal practices for injection equipment.*

FDA Label Image

Enoxaparin Winthrop 25

Packaging label for Enoxaparin Sodium Injection 30 mg/0.3 mL by Sanofi-Aventis U.S. LLC, featuring single-dose syringes with automatic safety device for subcutaneous injection. The label shows product name, strength, dosage form, package size of 10 syringes, manufacturer details, warnings, storage instructions, and directions for using the single-dose syringe safety device. The design includes the Winthrop and Sanofi logos with blue and purple color accents.*

FDA Label Image

Enoxaparin Winthrop 26

Box packaging label for Enoxaparin Sodium Injection 40 mg/0.4 mL by Sanofi-Aventis U.S. LLC. The label shows this is a single-dose syringe with an automatic safety device for subcutaneous injection, containing 10 syringes of 0.4 mL each. The label includes usage directions, storage instructions, manufacturer information, and barcode.*

FDA Label Image

Enoxaparin Winthrop 27

Packaging label for Enoxaparin Sodium Injection 60 mg/0.6 mL by Sanofi-Aventis U.S. LLC under the Winthrop brand. It includes 10 single-dose syringes with automatic safety devices for subcutaneous injection. The label features dosage information, storage instructions, manufacturer details, and instructions for syringe use with safety features.*

FDA Label Image

Enoxaparin Winthrop 28

Packaging label for Enoxaparin Sodium Injection 80 mg/0.8 mL by Sanofi-Aventis U.S. LLC. The carton contains 10 single-dose syringes with automatic safety devices for subcutaneous injection. The label includes dosage strength, manufacturer information, storage instructions, and directions for use with safety device activation illustrations. The product is Rx Only.*

FDA Label Image

Enoxaparin Winthrop 29

Packaging label for Enoxaparin Sodium Injection 100 mg/1 mL by Sanofi-Aventis U.S. LLC, featuring single dose syringes with automatic safety device for subcutaneous injection. The label shows the product name, strength, dosage form, quantity of 10 1 mL syringes, and storage instructions, along with manufacturer and barcode information. It also includes the Winthrop logo and dosage warnings.*

FDA Label Image

Enoxaparin Winthrop 30

Carton label for Enoxaparin Sodium Injection 300 mg/3 mL (100 mg/mL) by Sanofi-Aventis U.S. LLC under the Winthrop brand. The label shows a 3 mL multiple dose vial for subcutaneous or intravenous injection with storage and dosage instructions, manufacturer details, and barcode.*

FDA Label Image

Enoxaparin Winthrop 31

Packaging label for Enoxaparin Sodium Injection 120 mg/0.8 mL by Sanofi-Aventis U.S. LLC under the Winthrop brand. The carton contains 10 single-dose syringes with automatic safety devices for subcutaneous injection. The label provides storage instructions, dosage administration notes, and safety warnings, and displays the NDC 0955-1012-10.*

FDA Label Image

Enoxaparin Winthrop 32

The packaging label for Enoxaparin Sodium Injection 150 mg/1 mL by Sanofi-Aventis U.S. LLC, marketed under Winthrop. The box contains 10 single-dose syringes with an automatic safety device intended for subcutaneous injection. The label includes storage instructions and dosage information, along with illustrated directions for use of the syringe safety device.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.